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The objective of this study is to develop a novel system for local application of DOX either in surgical loci or in a topical
application device enabling a controlled release of the drug. The developed system involves the encapsulation of DOX
into electrospun polymeric nanofibers. Chosen polymers were polyoxyethilene (PEO) and polycaprolactone (PCL).
Objective
Introduction
Doxorubicin
(DOX)
Class I:
High permeability
High solubility
free DOX: 
low therapeutic 
index
repeated
administration 
of high doses 
are required
Experimental
Polymeric PEO solution
0.1 g/mL PEO in water
+
10 mg DOX Characterization
SEM-EDS
XRD
ATR-FTIR
Controlled release assays in cancer 
tissues ’conditions (pH 5.5 at 37°C)
Polymeric PCL solution
0.12 g/mL PCL in
chloroform : metanol (5:1)
+
10 mg DOX
Electrospinning parameters
Flow rate: 0,03 mL/h
Voltage: 20 kV
Needle: 0.3 mm
Room temperature
Electrospinning parameters
Flow rate: 0.6 mL/h
Voltage: 15 kV
Needle: 0.6 mm
Temperature: 20 ºC
XRD: 
Crystalline structure of polymer nanofibers
is not damaged by encapsulation of DOX.
Diffraction peak around 17º should reveal
the DOX within the fibers.
ATR-FTIR: 
It was possible to identify the vibrations from the most important functional groups in the
polymer fibers and in DOX (see table) but in fibers spectra, DOX peaks are not identified.
Why? 1. drug content is small (1.7-2.0%);
2. radiation penetration depth in the fibers is only around 1.7 mm;
Results
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PCL
PEO
SEM: 
PCL or PEO nanofibers
Estimated fiber diameters: 
from 200 nm to 2 µm
90 µm
8 µm
PCL
PEO
In the case of PCL-DOX nanofibers the fine mesh pores of
nanofibrous scaffolds created by interconnected nanofibers
and the diffusion of DOX through the nanofibrous layers as
an additional barrier could cause a more controlled and
prolonged release rate of about 20 % of drug in 40 h. Indeed
at the end of controlled release assays, PCL nanofiber
scaffold still reveals a great amount of color due to
incorporated DOX (Image A).
PEO nanofibers are water soluble and therefore one would
expect an immediate release of DOX from the nanofibers,
however a suspension with a gel appearance is formed inside
the dialysis bag (Image B) suggesting aggregates formation
between DOX and PEO monomers that hinder DOX release.
DOX-FIBER MESH 
INSIDE THE 
DIALYSIS BAG
Time 0 h
pH 5.5 BUFFER MIMETIC 
OF CANCER pH Time 55 h
DOX-PEO AGGREGATES 
INSIDE THE DIALYSIS 
BAG AT TIME 55 h
DOX-PCL NANOFIBER 
AT TIME 40 h
Conclusions
The electrospinning technique
proved to be efficient in
producing DOX loaded
nanofibers. PCL nanofibers,
by their mechanical resistance
and elasticity when compared
with PEO nanofibers, seem to
be a promising approach to
reach a sustained DOX
release profile. DOX-PCL
nanofiber meshes will be
tested in colorectal cancer
cells, for a therapeutic effect
by topical application.
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